I just realised I omitted the link in the last post.
After another 20min of searching, the company appears to have links to government. Support from the state may explain Fukangrens growth over the last 15 years - very large facilities, more than 500 chain pharmacies and cooperative hospitals and clinics, ties to universities & other educational institutions, ability to fast track approvals & financial support. http://www.ncsfgw.gov.cn/html/jjyw/2018-5-3/1407864689.html In 2018, when the central government was re-elected, the Central Government, the State Council, the National People's Congress, the CPPCC and other national institutions were reformed in a comprehensive manner. More than a dozen ministries and commissions (bureaus and offices) such as the State Food and Drug Administration, the Health and Development Commission, and the State Council Medical Reform Office were revoked and the National Medical Insurance Bureau and the market were established. General supervision and management, the State Construction Health Commission and other major restructuring, the new "Drug Administration Law" will soon be implemented. Large restructuring, great changes have come, from the development of the concept, the regulatory system, to the industry policy, industrial structure, etc. will be greatly changed, the pharmaceutical giant changes once again coming, how to meet pharmaceutical companies? Fukangren spoke at the conference about “Opportunities and Challenges for Chinese Pharmaceutical Enterprises to Enter into International Innovative Drugs“ providing input for the 19th National Congress of the Communist Party of China to implement the next Five-Year Plan. http://wemedia.ifeng.com/53936279/wemedia.shtml R&D head Professor Zhao Kang also holds the titles, Member of the Party Committee and Inspector of the Department of Education of Guangdong Province http://www.cdqzcz.com/News_Show.php?theId=1853
If it is the case, partnering with an institution backed by the PRC would appear to be a very good tie.
CDY Price at posting:
56.0¢ Sentiment: Buy Disclosure: Held
